Skip to menu Skip to content Skip to footer

2011

Journal Article

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study

Suppiah, Vijayaprakash, Gaudieri, Silvana, Armstrong, Nicola J., O'Connor, Kate S., Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Dore, Gregory J., Irving, William L., Powell, Elizabeth, Hellard, Margaret, Riordan, Stephen, Matthews, Gail, Sheridan, David, Nattermann, Jacob, Smedile, Antonina, Muller, Tobias, Hammond, Emma, Dunn, David, Negro, Francesco, Bochud, Pierre-Yves, Mallal, Simon, Ahlenstiel, Golo, Stewart, Graeme J., George, Jacob, Booth, David R. and for the International Hepatitis C Genetics Consortium (IHCGC) (2011). IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study. PLoS Medicine, 8 (9) e1001092, e1001092.1-e1001092.8. doi: 10.1371/journal.pmed.1001092

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: A cross-sectional study

2011

Journal Article

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

Smith, Katherine R., Suppiah, Vijayaprakash, O'Connor, Kate, Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Spengler, Ulrich, Bassendine, Margaret, Matthews, Gail, Irving, William L., Powell, Elizabeth, Riordan, Stephen, Ahlenstiel, Golo, Stewart, Graeme J., Bahlo, Melanie, George, Jacob and Booth, David R. (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine, 3 (8) 57. doi: 10.1186/gm273

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

2011

Journal Article

Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

Moschen, Alexander R., Fritz, Teresa Fritz, Clouston, Andrew D., Rebhan, Ilka, Bauhofer, Oliver, Barrie, Helen D., Powell, Elizabeth E., Kim, Soo-Hyun, Dinarello, Charles A., Bartenschlager, Ralf, Jonsson, Julie R. and Tilg, Herbert (2011). Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis. Hepatology, 53 (6), 1819-1829. doi: 10.1002/hep.24285

Interleukin-32: A new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

2011

Journal Article

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection

McPherson, Stuart, Powell, Elizabeth E., Barrie, Helen D., Clouston, Andrew D., McGuckin, Michael and Jonsson, Julie R. (2011). No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection. Journal of Gastroenterology and Hepatalogy, 26 (2), 319-327. doi: 10.1111/j.1440-1746.2010.06368.x

No evidence of the unfolded protein response in patients with chronic hepatitis C virus infection

2011

Conference Publication

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

Melino, Michelle, Gadd, Victoria L., Thomas, G. P., Walker, Gene V., Skoien, Richard, Clouston, Andrew D., Jonsson, Julie R. and Powell, Elizabeth E. (2011). Macrophage secretory products induce an inflammatory phenotype in hepatocytes. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL.

Macrophage secretory products induce an inflammatory phenotype in hepatocytes

2011

Conference Publication

Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis

Gadd, V.L., Roy, S., Clouston, A. D., Melino, M., Jonsson, J. R. and Powell, E. E. (2011). Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis. Australian Gastroenterology Week 2011, Brisbane, Australia, 12-15 September 2011. MALDEN: WILEY-BLACKWELL.

Characterisation of liver macrophages in chronic hepatitis C: role in an alternate pathway of liver regeneration and fibrosis

2011

Journal Article

Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?

Powell, Elizabeth E., Jonsson, Julie R. and Clouston, Andrew D. (2011). Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?. Gut, 60 (1), 1-2. doi: 10.1136/gut.2010.226365

Not every cell is as it seems: A role for ductular epithelial cells in fibrosis?

2011

Journal Article

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism

Barclay, JL, Nelson, CN, Ishikawa, M, Murray, LA, Kerr, LM, McPhee, TR, Powell, EE and Waters, MJ (2011). GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology, 152 (1), 181-192. doi: 10.1210/en.2010-0537

GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism

2010

Conference Publication

Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis

Melino, M., Powell, E. E., Gadd, V. L., Skoien, R., Walker, G., Clouston, A. D. and Jonsson, J. R. (2010). Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis. AGW2010: Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October, 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06450.x

Macrophage-secreted products induce a phenotypic change in hepatocytes: Implications for fibrogenesis

2010

Conference Publication

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

Skoien, R., Richardson, M. M., Jonsson, J. R., Powell, E. E. and Clouston, A. D. (2010). Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. Australian Gastroenterology Week 2010, Broadbeach, Qld., Australia, 20-23 October 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2010.06457.x

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

2010

Conference Publication

Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis

Skoien, R., Powell, E. E., Melino, M., Clouston, A. D., Gabrielli, B. G. and Jonsson, J. R. (2010). Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis. Australian Gastroenterology Week 2010, Gold Coast, QLD, Australia, 20-23 October 2010. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/j.1440-1746.2010.06450.x

Fatty acids induce hepatocyte senescence in vitro: implications for pathogenesis in non-alcoholic steatohepatitis

2010

Conference Publication

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

Powell, Elizabeth E., Jonsson, Julie R. and Clouston, Andrew D. (2010). Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. Falk Symposium 171 on Liver and Metabolic Syndrome, Hannover, Germany, 15-18 October 2009. Basel, Switzerland: S. Karger AG. doi: 10.1159/000282084

Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases

2009

Journal Article

Combined approach for non-invasive measurement of liver pathology by MR

Cowin, Gary J., Jonsson, Julie R., McPherson, Stuart, Clouston, Andrew D., Benson, Mark, Powell, Elizabeth E. and Galloway, Graham J. (2009). Combined approach for non-invasive measurement of liver pathology by MR. Journal of Hepatology, 51 (6), 1083-1084. doi: 10.1016/j.jhep.2009.09.005

Combined approach for non-invasive measurement of liver pathology by MR

2009

Journal Article

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Suppiah, Vijayaprakash, Moldovan, Max, Ahlenstiel, Golo, Berg, Thomas, Weltman, Martin, Abate, Maria Lorena, Bassendine, Margaret, Spengler, Ulrich, Dore, Gregory J., Powell, Elizabeth, Riordan, Stephen, Sheridan, David, Smedile, Antonnia, Fragomeli, Vincenzo, Muller, Tobias, Bahlo, Melanie, Stewart, Graeme J., Booth, David R., George, Jacob and Hepatitis C Study (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nature Genetics, 41 (10), 1100-1104. doi: 10.1038/ng.447

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

2009

Journal Article

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

McPherson, S., Jonsson, J. R., Cowin, GJ, O'Rourke, P., Clouston, A. D., Volp, A., Horsfall, L., Jothimani, D., Fawcett, J., Galloway, G. J., Benson, M. and Powell, E. E. (2009). Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. Journal of Hepatology, 51 (2), 389-397. doi: 10.1016/j.jhep.2009.04.012

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered

2009

Journal Article

Kupffer cells and hepatocyte metabolism: A two-way street?

Powell, Elizabeth E., Waters, Michael J. and Jonsson, Julie R. (2009). Kupffer cells and hepatocyte metabolism: A two-way street?. Hepatology, 49 (2), 690-692. doi: 10.1002/hep.22801

Kupffer cells and hepatocyte metabolism: A two-way street?

2009

Journal Article

Hepatic progenitor cell–mediated regeneration and fibrosis: chicken or egg?

Clouston, A. D., Jonsson, J. R. and Powell, E. E. (2009). Hepatic progenitor cell–mediated regeneration and fibrosis: chicken or egg?. Hepatology, 49 (5), 1424-1426. doi: 10.1002/hep.22893

Hepatic progenitor cell–mediated regeneration and fibrosis: chicken or egg?

2009

Conference Publication

Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis

McPherson, S., Cowin, G., O'Rourke, P., Volp, A., Horsfall, L., Burke, L., Jonsson, J., Clouston, A., Fawcett, J., Galloway, G., Benson, M. and Powell, E. (2009). Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis. 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Copenhagen Denmark, Apr 22-26, 2009. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0168-8278(09)61011-4

Quantitation of Steatosis by Magnetic Resonance Imaging (Mri) and Spectroscopy (Mrs) in Liver Disease: Effect of Hepatic Fibrosis

2009

Conference Publication

IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis

Fritz, Teresa, Moschen, Alexander R., Jonsson, Julie R., Woerz, Ilka, Clouston, Andrew D., Kim, SooHyun, Dinarello, Charles A., Bartenschlager, Ralf, Powell, Elizabeth E. and Tilg, Herbert (2009). IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis. 60th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA, U.S.A., 30 October - 3 November 2009. Hoboken, NJ, U.S.A.: John Wiley & Sons. doi: 10.1002/hep.23300

IL:32: A new pro-inflammatory cytokine involved in HCV-related liver inflammation and fibrosis

2009

Conference Publication

Quantitation of steatosis by magnetic resonance imaging (MRI) and spectroscopy (MRS) in liver disease: effect of hepatic fibrosis and iron

McPherson, S., Cowin, G., O'Rourke, P., Volp, A., Horsfall, L., Burke, L., Jonsson, J.R., Clouston, A., Fawcett, J., Galloway, G., Benson, M. and Powell, E. (2009). Quantitation of steatosis by magnetic resonance imaging (MRI) and spectroscopy (MRS) in liver disease: effect of hepatic fibrosis and iron. Annual Meeting of the British Society of Gastroenterology, Glasgow, Scotland, 23-26 March 2009. London, United Kingdom: B M J Group.

Quantitation of steatosis by magnetic resonance imaging (MRI) and spectroscopy (MRS) in liver disease: effect of hepatic fibrosis and iron